PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-830

No announcements, no promotion.

I’ve had enough. That’s me done.

Have now decided to accept my punishment (loss) for 4 years of blind faith in the ability of the board to achieve a commercial outcome on anything, and have commenced my gradual exit from PAA. Although others disagree with my view, I must respect my personal business principles with respect to a lack of continual disclosure by the company, and their complete disregard for stakeholder updates. In my opinion, public companies are not a secret society and with no feedback they resemble a number of sects which rely on blind faith and obedience.

I would have preferred to have had more detailed information about the status of the various trials before making my decision but I am not prepared to wait for a quarterly which, based on past performance, will only offer table scraps and hyperbole.

I have enjoyed recent hotcopper banter and hope my exit will herald a new wave of share price growth for those remaining and I would wish good luck to all intending to stay for the long haul.